Avacta Group Plc Share Price London S.E.
Equities
GB0033519546
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
Sales 2023 | 2.32Cr 2.96Cr 245.77Cr | Sales 2024 * | 2.45Cr 3.12Cr 259.02Cr | Capitalization | 16Cr 20Cr 1.66TCr |
---|---|---|---|---|---|
Net income 2023 | -2.4Cr -3.06Cr -253.73Cr | Net income 2024 * | -2.7Cr -3.44Cr -285.45Cr | EV / Sales 2023 | 14 x |
Net cash position 2023 * | 1.62Cr 2.06Cr 171.27Cr | Net cash position 2024 * | 30.12L 38.37L 32Cr | EV / Sales 2024 * | 6.27 x |
P/E ratio 2023 |
-12.7
x | P/E ratio 2024 * |
-5.7
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 70.66% |
Latest transcript on Avacta Group Plc
Managers | Title | Age | Since |
---|---|---|---|
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 04/16/04 |
Matt Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 16/13/16 |
Michael Vinegrad
IRO | Public Communications Contact | - | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trevor Nicholls
BRD | Director/Board Member | 67 | 02/13/02 |
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 04/16/04 |
Paul Fry
BRD | Director/Board Member | 58 | 03/20/03 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 12TCr | |
+12.15% | 11TCr | |
-8.14% | 2.39TCr | |
-1.69% | 2.16TCr | |
-10.60% | 1.9TCr | |
-41.25% | 1.7TCr | |
-15.33% | 1.63TCr | |
+5.80% | 1.41TCr | |
+28.03% | 1.2TCr |